Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
21
URGN Quote, Financials, Valuation and Earnings
Last price:
$23.00
Seasonality move
:
-2.48%
Day range:
$22.89 - $23.71
52-week range:
$3.42 - $30.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11.35x
P/B ratio:
16.41x
Volume:
250.9K
Avg. volume:
946.1K
1-year change:
108.61%
Market cap:
$1.1B
Revenue:
$90.4M
EPS (TTM):
-$3.46
Earnings Data
Next earnings date for URGN
Mar 10
2026
Most recent earnings per share
-$0.69
Missed by $0.01
(Nov 6/2025)
Consensus Estimate
-$0.68
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
URGN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/10/2026 | Q4 | $41.4M | -- | -- | -$0.49 | -- |
| 11/06/2025 | Q3 | $32.5M | $27.5M | -$0.69 | -$0.68 | -$0.01 |
| 08/07/2025 | Q2 | $23.1M | $24.2M | -$1.05 | -$0.83 | -$0.22 |
| 05/12/2025 | Q1 | $22.7M | $20.3M | -$0.92 | -$0.80 | -$0.13 |
| 03/10/2025 | Q4 | $25.2M | $24.6M | -$0.80 | -$0.72 | -$0.08 |
| 11/06/2024 | Q3 | $24.2M | $25.2M | -$0.55 | -$0.82 | $0.27 |
| 08/13/2024 | Q2 | $24M | $21.8M | -$0.91 | -$0.83 | -$0.08 |
| 05/13/2024 | Q1 | $21.4M | $18.8M | -$0.97 | -$0.87 | -$0.10 |
| 03/14/2024 | Q4 | $22.6M | $23.5M | -$0.72 | -$0.68 | -$0.04 |
| 11/14/2023 | Q3 | -- | $20.9M | -$0.68 | -- | -- |
| 08/10/2023 | Q2 | -- | $21.1M | -$1.03 | -- | -- |
| 05/11/2023 | Q1 | -- | $17.2M | -$1.30 | -- | -- |
| 03/16/2023 | Q4 | -- | $18.1M | -$1.22 | -- | -- |
| 11/10/2022 | Q3 | -- | $16.1M | -$1.13 | -- | -- |
| 08/11/2022 | Q2 | -- | $16.6M | -$1.18 | -- | -- |
| 05/10/2022 | Q1 | -- | $13.6M | -$1.25 | -- | -- |
| 03/10/2022 | Q4 | -- | $16.2M | -$1.27 | -- | -- |
| 11/15/2021 | Q3 | -- | $11.4M | -$1.35 | -- | -- |
| 08/04/2021 | Q2 | -- | $13M | -$1.17 | -- | -- |
| 05/13/2021 | Q1 | -- | $7.5M | -$1.17 | -- | -- |
| 03/18/2021 | Q4 | -- | $8M | -$1.38 | -- | -- |
| 11/09/2020 | Q3 | -- | $3.5M | -$1.31 | -- | -- |
| 08/10/2020 | Q2 | -- | $372K | -$1.44 | -- | -- |
| 05/07/2020 | Q1 | -- | -- | -$1.79 | -- | -- |
| 03/02/2020 | Q4 | -- | -- | -$1.86 | -- | -- |
| 11/12/2019 | Q3 | -- | -- | -$1.06 | -- | -- |
| 08/09/2019 | Q2 | -- | $18K | -$1.08 | -- | -- |
| 05/09/2019 | Q1 | -- | -- | -$1.11 | -- | -- |
| 02/28/2019 | Q4 | -- | -- | -$1.46 | -- | -- |
| 11/12/2018 | Q3 | -- | $283K | -$1.28 | -- | -- |
| 08/14/2018 | Q2 | -- | $364K | -$1.14 | -- | -- |
| 05/15/2018 | Q1 | -- | $481K | -$0.88 | -- | -- |
| 03/15/2018 | Q4 | -- | $327K | -$0.74 | -- | -- |
| 11/14/2017 | Q3 | -- | $7.8M | -$0.02 | -- | -- |
| 08/14/2017 | Q2 | -- | -- | -$0.70 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -- | -$1.77 | -- |
UroGen Pharma Ltd. Earnings Questions
-
How Much did UroGen Pharma Ltd. Generate in Revenue Last Quarter?
UroGen Pharma Ltd. reported $27.5M worth of top line sales in its most recent quarter.
-
Did UroGen Pharma Ltd. Beat Earnings Last Quarter?
UroGen Pharma Ltd. announced earnings per share of -$0.69 which represents a miss of analyst forecast a -$0.68 per share.
-
Is UroGen Pharma Ltd. Profitable?
UroGen Pharma Ltd. reported $24.2M that represents $0.50 per share over the last quarter.
-
What is the Analyst Consensus for UroGen Pharma Ltd. EPS Next Year?
UroGen Pharma Ltd.'s earnings are forecast to decrease from -$2.96 per share to -$3.13 per share next year representing a decrease of -5.63%.
-
When is UroGen Pharma Ltd.'s Earnings Date?
UroGen Pharma Ltd.'s next earnings date is March 10, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
